Dr Jon Testing & Treatment Melbourne, FL - 32940

Dr Jon Testing & Treatment is categorized under Inspection Services in Melbourne, FL and active since 2013.

Dr Jon Testing & Treatment was established in 2013, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Inspection Services business, which does work in the B2B market, and is classified as a Inspection Services, under code number 561990 by the NAICS.

If you are seeking more information, feel free to contact Gary Jon Lovette at the company’s single location by writing to 1370 Bedford Drive # 102, Melbourne, Florida FL 32940 or by phoning (321) 256-3393. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Dr Jon Testing & Treatment
Contact Person: Gary Jon Lovette
Address: 1370 Bedford Drive # 102, Melbourne, Florida 32940
Phone Number: (321) 256-3393
Website Address: drlovette.com
Annual Revenue (USD): $0 to $49.999
Founded: 2013
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Inspection Services
SIC Code: 7389
NAICS Code: 561990
Share This Business:

Dr Jon Testing & Treatment was started in 2013 to provide professional Inspection Services under the SIC code 7389 and NAICS code 561990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.

Feel free to contact Gary Jon Lovette for inquiries that concern Dr Jon Testing & Treatment by calling the company number (321) 256-3393, as your correspondence is most welcome. Additionally, the physical location of the single location of Dr Jon Testing & Treatment can be found at the coordinates 28.229581,-80.705499 as well as the street address 1370 Bedford Drive # 102 in Melbourne, Florida 32940.

For its online presence, you may visit Dr Jon Testing & Treatment’s website at drlovette.com and engage with its social media outlets through on Twitter and on Facebook.